Everolimus as a treatment of Chronic Lung Alograft Rejection (CLAD) in lung transplantation.
D. Iturbe Fernández (Santander, Spain), A. De Pablo Gafas (Madrid, Spain), K. Escobar Ramírez (Santander, Spain), . Ruiz Sáinz (Santander, Spain), V. Pérez González (Madrid, Spain), V. Mora Cuesta (Santander, Spain), S. Fernández Rozas (Santander, Spain), R. Alonso Moralejo (Madrid, Spain), J. Cifrián Martínez (Santander, Spain)
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Session: Lung transplantation: from bench to bedside
Session type: Thematic Poster
Number: 1103
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Iturbe Fernández (Santander, Spain), A. De Pablo Gafas (Madrid, Spain), K. Escobar Ramírez (Santander, Spain), . Ruiz Sáinz (Santander, Spain), V. Pérez González (Madrid, Spain), V. Mora Cuesta (Santander, Spain), S. Fernández Rozas (Santander, Spain), R. Alonso Moralejo (Madrid, Spain), J. Cifrián Martínez (Santander, Spain). Everolimus as a treatment of Chronic Lung Alograft Rejection (CLAD) in lung transplantation.. 1103
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: